Testing effectiveness (Phase 2)Ended earlyNCT03212716
What this trial is testing
Efficiency of Antagonist Drugs of the Cellular Transcriptomic Signature of Influenza A Virus Infection.
Who this might be right for
Flu
University Hospital, Lille 85
Showing 4 of 4 results